New research reveals why cancer patients may have lower Alzheimer's risk. Scientists discover that cancer releases a ...
Stockhead on MSN
Biocurious: In a drug-development wasteland, Actinogen zeroes in on an effective Alzheimer’s disease treatment
While Alzheimer's drug developers have spent US$50 billion on suboptimal treatments, Actinogen strives for a breakthrough ...
Alzheimer’s memory loss may be linked to disrupted brain activity during rest, when recent experiences are usually replayed and saved.
Scientists discovered why some neurons resist tau toxicity, identifying CRL5SOCS4 as a crucial defense and linking ...
STOCKHOLM, SE / ACCESS Newswire / February 3, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the n ...
Two Gold Coast patients have become the first in Queensland to receive new medications which doctors hope may offer a better ...
Recent years have marked a turning point in dementia research and care, with the approval of new, high-cost disease-modifying treatments for Alzheimer’s ...
Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy ...
Monash University researchers, in collaboration with Harvard University, have discovered how to permanently "switch off" ...
On telehealth, value-based care, diabetes prevention, doctor burnout and more, members of Congress have worked to find common ground.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results